Latest filing published 23 May 2024 for Alzecure AB, €6,881.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Eva Lilienberg: trading record in brief
This profile gathers the share dealings of Eva Lilienberg across 2 companies, led by AlzeCure Pharma AB and Alzecure AB. The record holds 4 filings, for trades running from 14 March 2022 to 21 May 2024.
Every open-market trade on record is a purchase: 1 purchase worth €961, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 23 May 2024, reports a transaction of €6,881 in Alzecure AB. The last purchase on record was published on 23 March 2022, which is 1,691 days ago. The median gap between a trade and its publication by Finansinspektionen is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Eva Lilienberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 47,000 shares@ SEK 1.70100.0% of flowBTA (betald tecknad aktie)ISIN SE0022060802FI:csv-8b32c5ce27c9a089d1f8
- 12,500 shares@ SEK 1.7065.5% of flowBTA (betald tecknad aktie)ISIN SE0022060802FI:csv-4bcc7a6ef49bc97e257a
- 2,500 shares@ SEK 4.0034.5% of flowBTA (betald tecknad aktie)ISIN SE0010133785FI:csv-0f9de7677b49c3fac392Canonical exit: 19 Jun 2022 (T+90)
- 62,500 shares0Teckningsrätt/UniträttISIN SE0017563190FI:csv-945ca413ba14e9f86ace
4 of 4 declarations